| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Hamer John is a Director at AbCellera Biologics Inc.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $713K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | ABCL Abcellera Biologics Inc. | Director | Sell | 300,000 | $16.94 | $5,082,252.98 | -43.2% | -11.6% | -34.6% |